MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Nepafenac Once Daily for Macular Edema - Study 1

Phase 3
Completed
Conditions
Non-Proliferative Diabetic Retinopathy
Cataract
Interventions
Drug: Nepafenac Ophthalmic Suspension, 0.3%
Other: Nepafenac vehicle
Drug: Prednisolone acetate
First Posted Date
2013-05-14
Last Posted Date
2016-08-03
Lead Sponsor
Alcon Research
Target Recruit Count
881
Registration Number
NCT01853072

ESBA1008 Microvolume Study

Phase 2
Completed
Conditions
Exudative Age-Related Macular Degeneration
Interventions
Drug: ESBA1008 solution
Drug: Ranibizumab
First Posted Date
2013-05-08
Last Posted Date
2016-03-24
Lead Sponsor
Alcon Research
Target Recruit Count
107
Registration Number
NCT01849692

Intra-Operative Metrics With CENTURION® and INFINITI® Vision Systems

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: CENTURION® Vision System (CVS)
Device: INFINITI® Vision System (IVS)
First Posted Date
2013-05-07
Last Posted Date
2015-04-07
Lead Sponsor
Alcon Research
Target Recruit Count
112
Registration Number
NCT01848288

Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Hyperopia
Refractive Error
Interventions
Device: Nelfilcon A contact lenses
Device: Etafilcon A contact lenses
Device: Omafilcon A contact lenses
First Posted Date
2013-04-24
Last Posted Date
2014-06-20
Lead Sponsor
Alcon Research
Target Recruit Count
30
Registration Number
NCT01839318

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Phase 1
Completed
Conditions
Age-related Macular Degeneration
Interventions
Drug: CLG561
First Posted Date
2013-04-18
Last Posted Date
2016-03-25
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT01835015

Efficacy and Safety Study of FID 119515A

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: Blink® Tears
Other: FID 119515A
First Posted Date
2013-04-16
Last Posted Date
2018-06-29
Lead Sponsor
Alcon Research
Target Recruit Count
75
Registration Number
NCT01833117

Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution

Not Applicable
Completed
Conditions
Refractive Error
Presbyopia
Myopia
Hyperopia
Astigmatism
Interventions
Device: Lotrafilcon B contact lenses
Device: Senofilcon A contact lenses
Device: Habitual Multi-Purpose Solution (MPS)
Device: OPTI-FREE PureMoist Multi-Purpose Disinfecting Solution (MPDS)
First Posted Date
2013-03-12
Last Posted Date
2014-07-22
Lead Sponsor
Alcon Research
Target Recruit Count
387
Registration Number
NCT01809197

Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens

Not Applicable
Completed
Conditions
Presbyopia
Myopia
Ametropia
Refractive Error
Interventions
Device: Nelfilcon A multifocal contact lens with comfort additive
Device: Nelfilcon A multifocal contact lens
First Posted Date
2013-02-25
Last Posted Date
2014-05-23
Lead Sponsor
Alcon Research
Target Recruit Count
83
Registration Number
NCT01797783

Efficacy and Safety Study of ESBA1008 Versus EYLEA®

Phase 2
Completed
Conditions
Exudative Age-Related Macular Degeneration
Interventions
Drug: ESBA1008 solution
Drug: Aflibercept
First Posted Date
2013-02-22
Last Posted Date
2016-02-09
Lead Sponsor
Alcon Research
Target Recruit Count
173
Registration Number
NCT01796964

A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers

Not Applicable
Completed
Conditions
Myopia
Refractive Error
Interventions
Device: Lotrafilcon B contact lens with color
Device: Phemfilcon A contact lens with color
First Posted Date
2013-02-04
Last Posted Date
2014-05-09
Lead Sponsor
Alcon Research
Target Recruit Count
574
Registration Number
NCT01782482
© Copyright 2025. All Rights Reserved by MedPath